TARGET CELL DAMAGE BY IMMUNE MECHANISMS
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
批准号:
3774385
负责人:
P A HENKART
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
--
资助国家:
美国
项目状态:
未结题
起止时间:
至
关键词:
DNA damage apoptosis aprotinin cell mediated cytotoxicity cell mediated lymphocytolysis test cellular immunity chymotrypsin cytolysins cytolysis cytotoxic T lymphocyte exocytosis granule immunofluorescence technique laboratory rat leukocyte activation /transformation mast cell neoplasm molecular cloning serine proteinases transfection trypsin western blottings
中文摘要
为了测试颗粒胞吐模型对淋巴细胞的细胞毒性,
我们检测了大鼠粘膜肥大细胞瘤的细胞毒活性。
细胞毒性淋巴细胞颗粒基因转染系RBL的研究
组件。我们已经构建了三重、双倍和单倍RBL
表达细胞溶素(Cy)和颗粒丝氨酸蛋白酶的转染体
颗粒酶A(GZA)和颗粒酶R(GZB)。RBL-Cy转染体仅显示
对肿瘤靶点的适度细胞毒性,没有伴随的靶DNA
退化。而RBL-GZA转染体在可比水平上表达GZA
为了克隆CTL并将其分泌以响应Iger交联物,他们已经
未检测到细胞毒活性。Rbl-Cy-GZA转基因克隆显示
这两种颗粒成分的良好表达显示了细胞溶解活性
在RBC靶点上与RBL-Cy相当,但比RBC靶点高3倍以上
三个不同的肿瘤靶点。这种细胞毒性伴随着
目标DNA碎片。为了确认杀伤细胞颗粒酶需要
进入靶细胞,我们将大分子加载到靶细胞中
蛋白水解酶抑制剂抑肽酶,通过渗透裂解胞质小体。与.相比
BSA加载靶向或未加载靶向,抑肽酶靶向较少
CTL和RBL转染体对裂解和DNA破坏敏感
然而,表达颗粒酶A的RBL转染体仅表达
细胞溶血素对牛血清白蛋白和抑肽酶靶点的裂解作用
效率。作为对蛋白酶诱导能力的直接测试
细胞毒性当被引入靶细胞的细胞质中时,我们有
利用渗透裂解将不同的蛋白水解酶“注入”肿瘤细胞
针小体。内切酶胰酶、胰凝乳酶和蛋白酶K分别为
一剂就能溶解几种不同类型的肿瘤细胞
依赖方式,通过51Cr释放来衡量。这起死亡事件总体上是
通过形态标准和DNA片段化来判断细胞的凋亡率。
英文摘要
In order to test the granule exocytosis model for lymphocyte cytotoxicity,
we have examined the cytotoxic activity of the rat mucosal mast cell tumor
line RBL after transfection with genes for cytotoxic lymphocyte granule
components. We have constructed triple, double, and single RBL
transfectants expressing cytolysin (cy) and the granule serine proteases
granzyme A (gza) and granzyme R (gzb). RBL-cy transfectants show only
modest cytotoxicity on tumor targets, with no accompanying target DNA
degradation. While RBL-gza transfectants express gza at levels comparable
to cloned CTL and secrete it in response to IgER cross-linking, they have
no cytotoxic activity detectable. RBL-cy-gza transfectant clones showing
good expression of both these granule components showed cytolytic activity
comparable to RBL-cy on RBC targets, but were greater than 3x more lytic
on three different tumor targets. This cytotoxicity is accompanied by
target DNA fragmentation. To confirm that killer cell granzymes need to
enter the target cell, we loaded target cells with the macromolecular
protease inhibitor aprotinin by osmotic lysis of pinosomes. Compared to
BSA-loaded targets or unloaded targets, aprotinin-targets were less
susceptible to lysis and DNA breakdown by CTL and RBL transfectants
expressing granzyme A. However, RBL transfectants expressing only
cytolysin lysed BSA-loaded and aprotinin-loaded targets with equal
efficiency. As a direct test of the ability of proteases to induce
cytotoxicity when introduced into the cytoplasm of a target cell, we have
"injected" various proteases into tumor cells using osmotic lysis of
pinosomes. The endoproteases trypsin, chymotrypsin, and proteinase K were
all found to lyse several different types of tumor cells in a dose
dependent manner, as measured by 51Cr release. This death was generally
apoptotic by morphological criteria and DNA fragmentation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6100954
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3796537
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3774389
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6161048
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3752092
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
APOPTOTIC DEATH IN T LYMPHOCYTES
-
批准号:6161054
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3813453
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3916398
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC AND HELPER T LYMPHOCYTE GRANULES
-
批准号:3916408
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:3796542
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:3962935
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
MEMBRANE DAMAGE BY IMMUNE MECHANISMS
-
批准号:4691749
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
PROGRAMMED CELL DEATH IN LYMPHOCYTES
-
批准号:5201007
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:5201003
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3939239
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:6100948
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:4691768
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3808591
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
STRUCTURE AND FUNCTION OF CYTOTOXIC T LYMPHOCYTE GRANULES
-
批准号:3962951
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
TARGET CELL DAMAGE BY IMMUNE MECHANISMS
-
批准号:3752088
-
项目类别:
-
资助金额:$0.0万
-
财政年份:--
-
负责人:P A HENKART
-
依托单位:
国内基金
海外基金
登录
查看更多内容
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
-
批准号:LBY21H010001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2020
-
负责人:郑绪阳
-
依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
-
批准号:81703335
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:卫高菲
-
依托单位:
双肝移植后Apoptosis和pyroptosis在移植物萎缩差异中的作用和供受者免疫微环境变化研究
-
批准号:81670594
-
项目类别:面上项目
-
资助金额:58.0万元
-
批准年份:2016
-
负责人:陈昊
-
依托单位:
Serp-2 调控apoptosis和pyroptosis 对肝脏缺血再灌注损伤的保护作用研究
-
批准号:81470791
-
项目类别:面上项目
-
资助金额:73.0万元
-
批准年份:2014
-
负责人:董家鸿
-
依托单位:
Apoptosis signal-regulating kinase 1是七氟烷抑制小胶质细胞活化的关键分子靶点?
-
批准号:81301123
-
项目类别:青年科学基金项目
-
资助金额:23.0万元
-
批准年份:2013
-
负责人:王海莲
-
依托单位:
APO-miR(multi-targeting apoptosis-regulatory miRNA)在前列腺癌中的表达和作用
-
批准号:81101529
-
项目类别:青年科学基金项目
-
资助金额:22.0万元
-
批准年份:2011
-
负责人:陈雪芹
-
依托单位:
放疗与细胞程序性死亡(APOPTOSIS)相关性及其应用研究
-
批准号:39500043
-
项目类别:青年科学基金项目
-
资助金额:9.0万元
-
批准年份:1995
-
负责人:梁克
-
依托单位: